Amityville, NY—The FDA has granted approval to Hi-Tech Pharmacal Co.'s Abbreviated New Drug Application for ciprofloxacin ophthalmic solution USP, 0.3%.
Amityville, NY-The FDA has granted approval to Hi-Tech Pharmacal Co.'s Abbreviated New Drug Application for ciprofloxacin ophthalmic solution USP, 0.3%.
This is the generic equivalent of Alcon Laboratories' Ciloxan Ophthalmic Solution, 0.3%, which is indicated for the treatment of bacterial infections.
